News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Articles|February 27, 2008

Humira approved for juvenile rheumatoid arthritis

Abbott's Humira (adalimumab) had been approved by the food and Drug Administration for its sixth indication, juvenile rheumatoid arthritis...

Abbott's Humira (adalimumab) has been approved by the Food and Drug Administration for its sixth indication, juvenile rheumatoid arthritis.

JVA joins other indications including chronic plaque psoriasis, rheumatoid arthritis in adults, and Crohn's disease.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

PECOS study identifies 20 post-COVID symptoms in children, from fatigue to cardiac and mental health effects

PECOS study identifies 20 post-COVID symptoms in children, from fatigue to cardiac and mental health effects

ByRoberta L. DeBiasi, MD, MS

July 20th 2026

Joyce Woo, MD, on how rapid diagnosis and transfer remain critical in severe heart defects

Joyce Woo, MD, on how rapid diagnosis and transfer remain critical in severe heart defects

ByJoyce Woo, MD, MS

July 20th 2026

FAQ: What does the new "faltering weight" guideline mean for your practice? | Image Credit: © Rawpixel.com - stock.adobe.com.

FAQ: What does the new "faltering weight" guideline mean for your practice?

ByContemporary Pediatrics Staff

July 20th 2026

Later transfer linked to longer hospitalization in severe congenital heart defects

Joyce Woo, MD, on how hospital factors may influence cardiac transfer timing for newborns

ByJoyce Woo, MD, MS

July 17th 2026

Pertussis resurgence: An expert Q&A on diagnostic delays and point-of-care testing

Pertussis resurgence: An expert Q&A on diagnostic delays and point-of-care testing

ByAlesia McKeown, PhD

July 17th 2026

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

PECOS study identifies 20 post-COVID symptoms in children, from fatigue to cardiac and mental health effects

RSV Prevention and Vaccine Hesitancy: Building Long-Term Communication

FAQ: What does the new "faltering weight" guideline mean for your practice?

Pertussis resurgence: An expert Q&A on diagnostic delays and point-of-care testing

Joyce Woo, MD, on how rapid diagnosis and transfer remain critical in severe heart defects